Lexicon Pharmaceuticals
LXRX
#6822
Rank
C$1.09 B
Marketcap
C$2.45
Share price
-1.15%
Change (1 day)
13.34%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : C$0.10 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company's total liabilities are C$0.10 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Lexicon Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31C$0.10 B-51.52%
2024-12-31C$0.21 B21.01%
2023-12-31C$0.18 B72.65%
2022-12-31C$0.10 B252.46%
2021-12-31C$29.71 M-50.86%
2020-12-31C$60.45 M-84.6%
2019-12-31C$0.39 B-7.19%
2018-12-31C$0.42 B-8.64%
2017-12-31C$0.46 B8.27%
2016-12-31C$0.42 B-15.8%
2015-12-31C$0.50 B133.58%
2014-12-31C$0.21 B96.4%
2013-12-31C$0.11 B5.93%
2012-12-31C$0.10 B-22.72%
2011-12-31C$0.13 B12.87%
2010-12-31C$0.11 B20.8%
2009-12-31C$99.18 M24.2%
2008-12-31C$79.86 M-3.23%
2007-12-31C$82.52 M-32.34%
2006-12-31C$0.12 B-21.17%
2005-12-31C$0.15 B42.54%
2004-12-31C$0.10 B-29.07%
2003-12-31C$0.15 B204.06%
2002-12-31C$50.33 M46.16%
2001-12-31C$34.43 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Thermo Fisher Scientific
TMO
C$85.98 B 79,817.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$5.53 B 5,040.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$14.27 B 13,164.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
C$2.20 B 1,949.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$1.73 B 1,512.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C$1.09 B 920.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
C$0.76 B 614.33%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$7.69 B 7,051.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
C$4.43 M-95.88%๐Ÿ‡บ๐Ÿ‡ธ USA